Zhen-Feng Chen

Prof. Zhen-Feng Chen


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 February 2015 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
ZCZhen-Feng Chen
Zhen-Feng Chen
QQQi-Pin Qin
Qi-Pin Qin
JQJiao-Lan Qin
Jiao-Lan Qin
YLYan-Cheng Liu
Yan-Cheng Liu
KHKe-Bin Huang
Ke-Bin Huang
HLHong Liang
Hong Liang

30 August 2018 in Green Chemistry
Verified
Journal Article
Closed access
PDF file
ZMZu-Yu Mo
Zu-Yu Mo
TSToreshettahally R. Swaroop
Toreshettahally R. Swaroop
WTWei Tong
Wei Tong
YZYu-Zhen Zhang
Yu-Zhen Zhang
HTHai-tao Tang
Hai-tao Tang
ZCZhen-Feng Chen
Zhen-Feng Chen
An efficient electrochemical transformation of structurally diverse sulfonyl hydrazides and thiols into thiosulfonates in the presence of ammonium iodide as redox catalyst and electrolyte in acetonitrile at ambient temperature is reported. Transition metal- and oxidant-free conditions are the striking features of this protocol. The in vitro cytotoxicity of all compounds is evaluated by MTT assay against four human cancer cell lines. The results reveal that 3ac and 3ag exhibit potential inhibitory activity against tumor cells. Furthermore, 3ag inhibits cell migration ability and tubulin polymerization in T-24 cells, leading to cell cycle arrest and apoptosis.


2 April 2018 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
KHKe-Bin Huang
Ke-Bin Huang
FWFeng-Yang Wang
Feng-Yang Wang
XTXiao-Ming Tang
Xiao-Ming Tang
HFHai-Wen Feng
Hai-Wen Feng
ZCZhen-Feng Chen
Zhen-Feng Chen
HLHong Liang
Hong Liang

24 April 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JQJiao-Lan Qin
Jiao-Lan Qin
WSWen-Ying Shen
Wen-Ying Shen
ZCZhen-Feng Chen
Zhen-Feng Chen
LZLi-Fang Zhao
Li-Fang Zhao
QQQi-Pin Qin
Qi-Pin Qin
HLHong Liang
Hong Liang
Three new oxoaporphine Co(II), Ni(II) and Zn(II) complexes 1–3 have been synthesized and fully characterized. 1–3 have similar mononuclear structures with the metal and ligand ratio of 1:2. 1–3 exhibited higher cytotoxicity than the OD ligand and cisplatin against HepG2, T-24, BEL-7404, MGC80–3 and SK-OV-3/DDP cells, with IC50 value of 0.23−4.31 μM. Interestingly, 0.5 μM 1–3 significantly caused HepG2 arrest at S-phase, which was associated with the up-regulation of p53, p21, p27, Chk1 and Chk2 proteins, and decrease in cyclin A, CDK2, Cdc25A, PCNA proteins. In addition, 1–3 induced HepG2 apoptosis via a caspase-dependent mitochondrion pathway as evidenced by p53 activation, ROS production, Bax up-regulation and Bcl-2 down-regulation, mitochondrial dysfunction, cytochrome c release, caspase activation and PARP cleavage. Furthermore, 3 inhibited tumor growth in HepG2 xenograft model, and displayed more safety profile in vivo than cisplatin.

7 March 2022 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
WSWen-Ying Shen
Wen-Ying Shen
CJChun-Peng Jia
Chun-Peng Jia
LLLi-Yi Liao
Li-Yi Liao
LCLiu-Lin Chen
Liu-Lin Chen
CHCheng Hou
Cheng Hou
ZCZhen-Feng Chen
Zhen-Feng Chen